A Clinical Trial to ascertain the effect of Homoeopathic Medicines in prevention of outbreak of symptoms in asymptomatic Corona virus and suspected Corona virus patients

Phase 3

Not yet recruiting

• Conditions: Coronavirus as the cause of diseases classified elsewhere,

• Registration Number: CTRI/2020/04/024926
• Lead Sponsor: Naiminath Homoeopathic Medical College Hospital and Research Centre

Brief Summary

Theprimary aim of this study is to assess the effect of Homoeopathic treatment inarresting the pathogenesis of disease in asymptomatic infected corona viruspatients as well as suspected patients who are placed in quarantine. We willalso evaluate the time of recovery of such patients after Homoeopathicintervention. In cases where symptoms do appear after the intervention, timetaken to reach that stage will be evaluated in order to study the effect ofHomoeopathic intervention during this stage of the pathogenesis of the disease.Suspected patients who are not confirmed Corona virus positive, waiting for thetest results but are placed in quarantine will also be given Homoeopathicmedicine under this trial and the test results will be evaluated thereafter tostudy the effect of Homoeopathic treatment for such patients.

Effective Homoeopathic treatment forthis section of patients can be a game changer in this pandemic since it mayprove to be a vital treatment against corona virus infection when it is inearly stage of pathogenesis.

Detailed Description

Not available

Study Timeline

• Study Start: 2020-10-05

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• •Asymptomatic patients confirmed positive with COVID-19 tests criteria will be included.
• •Suspected corona virus patients who are quarantined will also be included.
• •Patients with age groups of 5-70 years.
• •Patients who are willing to give informed consent for treatment.

Exclusion Criteria

• •Symptomatic patients confirmed positive with COVID-19 tests criteria will be included.
• •More than 70 years of age and less than age of 5 years.
• •Subjects considered not suitable for the study by the researchers.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Primary endpoint of this trial will be measured in terms of clinically recovered case (Covid-19 negative) or appearance of symptoms where conventional treatment starts	21 days

Secondary Outcome Measures

Name	Time	Method
Improvement in the quality of life w.r.t. activity, appetite, sleep and general condition of the patient.	4 days
Suspected cases in quarantine confirmed as negative	14 days/ until discharge

Trial Locations

Locations (1)

Naiminath Homoeopathic Medical College, Hospital and Research Centre; 🇮🇳 Agra, UTTAR PRADESH, India

Naiminath Homoeopathic Medical College, Hospital and Research Centre

🇮🇳Agra, UTTAR PRADESH, India

Dr Ritu Gupta

Principal investigator

8193896328

ritudrgupta@gmail.com